intervju med Isabelle p\u00e5 Forskning.no<\/a><\/p>\n[\/et_pb_text][\/et_pb_column][et_pb_column type=»1_3″][et_pb_sidebar admin_label=»Nyhetsarkiv og konferanser» orientation=»left» area=»primary» background_layout=»light» remove_border=»off»]<\/p>\n
<\/p>\n
[\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"
[et_pb_section admin_label=»Seksjon» fullwidth=»on» specialty=»off»][et_pb_fullwidth_post_title admin_label=»Fullbreddes innleggstittel» title=»on» meta=»off» author=»on» date=»on»...<\/p>\n","protected":false},"author":4078,"featured_media":5533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174711],"tags":[],"class_list":["post-4489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-forside-6"],"_links":{"self":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/users\/4078"}],"replies":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/comments?post=4489"}],"version-history":[{"count":22,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4489\/revisions"}],"predecessor-version":[{"id":5721,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4489\/revisions\/5721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/media\/5533"}],"wp:attachment":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/media?parent=4489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/categories?post=4489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/tags?post=4489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/Robert.jpg\")
<\/span>![\"\"](\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/HanesThesis-156x225.jpg\")
<\/span>MSc Robert Hanes<\/strong> ved Tumorbiologisk seksjon, Institutt for kreftforskning (OUS – Radiumhospitalet) forsvarte sin avhandling «Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma» 25\/1-18. Opponenter var\u00a0<\/span>Dr. Sandra Strauss, University College London (UCL) Cancer Institute, London, Group leader Antoni Wiedlocha, Oslo University Hospital, og Professor emeritus Tom Kristensen, University of Oslo.<\/p>\n![\"\"](\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/isabelle.jpg\")
![\"\"](\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/IsabelleThesis-152x225.jpg\")
<\/span><\/a>MA\u00a0Isabelle Sylvie Budin Lj\u00f8sne<\/strong> ved Institutt for helse og samfunn (UiO) forsvarte sin PhD-avhandling «Bringing personalized medicine to people»<\/a> 27\/4-18. Opponenter var\u00a0Dr. Eric Meslin, President and CEO, Council of Canadian Academies, Professor Effy Vayena, Institute of Translational Medicine, Eidgen\u00f6ssische Technische Hochschule (ETH) Z\u00fcrich, og Professor Emeritus Gerd Holmboe-Ottesen, Institutt for helse og samfunn, Universitetet i Oslo.<\/p>\n